Evolution of uncontrolled proliferation and the angiogenic switch in cancer

Mathematical Biosciences and Engineering

Volumn 9, Issue 4, 2012, Pages 843-876

  Nagy, John D ^a   Armbruster, Dieter ^b  

^a Scottsdale Community College   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Adaptive dynamics; ATP; Cancer; Energy charge; Evolutionary suicide; Multiscale models; Perturbation expansion

Indexed keywords

ANGIOGENIC PROTEIN;

ANIMAL; ARTICLE; BIOLOGICAL MODEL; CELL PROLIFERATION; COMPUTER SIMULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR EVOLUTION; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); PATHOLOGY; PATHOPHYSIOLOGY; REGULATOR GENE;

ANGIOGENIC PROTEINS; ANIMALS; CELL PROLIFERATION; COMPUTER SIMULATION; EVOLUTION, MOLECULAR; GENES, SWITCH; HUMANS; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC;

EID: 84867808798     PISSN: 15471063     EISSN: 15510018     Source Type: Journal    
DOI: 10.3934/mbe.2012.9.843     Document Type: Article

References (57)

1. rd edition, Garland, New York, 1994.
2. F. I. Ataullakhanov, S. V. Komarova, M. V. Martynov and V. M. Vitvitsky, A possible role of adenylate metabolism in human erythrocytes: 2. adenylate metabolism is able to improve the erythrocyte volume stabilization, J. Theor. Biol., 183 (1996), 307-316.
3. F. I. Ataullakhanov, S. V. Komarova and V. M. Vitvitsky, A possible role of adenylate metabolism in human erythrocytes: simple mathematical model, J. Theor. Biol., 179 (1996), 75-86.
4. F. I. Ataullakhanov and V. M. Vitvitsky, What determines the intracellular ATP concentration?, Biosci. Rep., 22 (2002), 501-511.
5. F. I. Ataullakhanov, V. M. Vitvitsky, A. M. Zhabotinsky, A. V. Pichugin, O. V. Platonova, B. N. Kholodenko and L. I. Ehrlich, The regulation of glycolysis in human erythrocytes: the dependence of the glycolytic flux on the ATP concentration, Eur. J. Biochem., 115 (1981), 359-365.
6. D. E. Atkinson, "Cellular Energy Metabolism and Its Regulation," Academic Press, New York, 1977.
7. L. E. Benjamin, I. Hemo and E. Keshet, A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF, Development, 125 (1998), 1591-1598.
8. T. Bønsdorff, M. Gautier, W. Farstad, K. Rønningen, F. Lingaas and I. Olsaker, Mapping of the bovine genes of the de novo AMP synthesis pathway, Anim. Genet., 35 (2004), 438-444.
9. J. J. Boza, D. Möennoz, C. E. Bournot, S. Blum, I. Zbinden, P. A. Finot and O. Ballèvre, Role of glutamine on the de novo purine nucleotide synthesis in Caco-2 cells, Eur. J. Nutr., 39 (2000), 38-46.
10. D. J. Brat and E. G. Van Meir, Vaso-occlusive and prothrombotic mechanisms associated with tumor hypoxia, necrosis, and accelerated growth in glioblastoma, Lab. Invest., 84 (2004), 397-405.
11. J. P. Collins, "Evolutionary ecology" and the use of natural selection in ecological theory, J. Hist. Biol., 19 (1986), 257-288.
12. J. de Grouchy and C. de Nava, A chromosomal theory of carcinogenesis, Ann. Intern. Med., 69 (1968), 381-391.
13. F. Du, X.-H. Zhu, Y. Zhang, M. Friedman, N. Zhang adn K. Uqurbil and W. Chen, Tightly coupled brain activity and cerebral ATP metabolic rate, Proc. Nat. Acad. Sci. USA, 105 (2008), 6409-6414.
14. I. F. Dunn, O. Heese and P. McL. Black, Growth factors in glioma angiogenesis: FGFs, PDGF, EGF, and TGFs, J. Neuro-Onco., 50 (2000), 121-137.
15. D. Gammack, H. M. Byrne and C. E. Lewis, Estimating the selective advantage of mutant p53 tumour cells to repeated rounds of hypoxia, Bull. Math. Biol., 63 (2001), 135-166.
16. S. A. H. Geritz, É. Kisdi, G. Meszéna and J. A. J. Metz, Evolutionarily singular stategies and the adaptive growth and branching of the evolutionary tree, Evol. Ecol., 12 (1998), 35-57.
17. th edition, Saunders, Philadelphia, 1973.
18. M. Greaves, Darwinian medicine: A case for cancer, Nature Rev. Cancer, 7 (2007), 213-221.
19. M. Greaves and C. C. Maley, Clonal evolution in cancer, Nature, 481 (2012), 306-313.
20. D. Hanahan and J. Folkman, Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis, Cell, 86 (1996), 353-364.
21. D. Hanahan and R. A. Weinberg, The hallmarks of cancer, Cell, 100 (2000), 57-70.
22. D. Hanahan and R. A. Weinberg, Hallmarks of cancer: The next generation, Cell, 144 (2011), 646-674.
23. D. G. Hardie, D. Carling and M. Carlson, The AMP-activated/SNF1 protein kinase subfamily: Metabolic sensors of the eukaryotic cell?, Ann. Rev. Biochem., 67 (1998), 821-855.
24. T. S. Hauschka, The chromosomes in ontogeny and oncogeny, Cancer Res., 21 (1961), 957-974.
25. J. Holash, P. C. Maisonpierre, D. Compton, P. Boland, C. R. Alexander, D. Zagzag, G. D. Yancopolous and S. J. Weigand, Vessel cooperation, regression and growth in tumors mediated by angiopoietins and VEGF, Science, 221 (1998), 1994-1998.
26. J. Maynard Smith, "Evolution and the Theory of Games," Cambridge University Press, Cambridge, 1982.
27. J. Maynard Smith and G. R. Price, The logic of animal conflict, Nature, 246 (1973), 15-18.
28. A. Joshi and B. O. Palsson, Metabolic dynamics in the human red cell. Parts 1-2, J. Theor. Biol., 141 (1989), 515-545.
29. A. Joshi and B. O. Palsson, Metabolic dynamics in the human red cell. Parts 3-4, J. Theor. Biol., 142 (1990), 41-85.
30. W. G. Kaelin and P. J. Ratcliffe, Oxygen sensiing by metazoans: The central role of the HIF hydroxylase pathway, Mol. Cell, 30 (2008), 393-402.
31. G. Karoubi, D. J. Stewart and D. W. Courtman, A population analysis of VEGF transgene expression and secretion, Biotech. Bioeng., 101 (2008), 1083-1093.
32. B. Kaur, C. Tan, D. J. Brat, D. E. Post and E. G. Van Meir, Gene and hypoxic regulation of angiogenesis in gliomas, J. Neuro-Oncol., 70 (2004), 229-243.
33. D. G. Kilburn, M. D. Lilly and F. C. Webb, The energetics of mammalian cell growth, J. Cell Sci., 4 (1969), 645-654.
34. L. A. Lai, R. Kostadivov, M. T. Barrett, D. A. Peiffer, D. Pokholok, R. Odze, C. A. Sanchez, C. C. Maley, B. J. Reid, K. L. Gunderson and P. S. Rabinovitch, Deletion at fragile sites is a common and early event in Barrett's esophagus, Mol. Cancer Res., 8 (2010), 1084-1094.
35. L. W. Law, Origin of the resistance of leukaemic cells to folic acid antagonists, Nature, 169 (1952), 628-629.
36. A. M. Leroi, V. Koufopanou and A. Burt, Cancer selection, Nature Rev. Cancer, 3 (2003), 226-231.
37. A. Levan and J. J. Biesele, Role of chromosomes in cancerogenesis, as studied in serial tissue culture of mammalian cells, Ann. N. Y. Acad. Sci., 71 (1958), 1022-1053.
38. M. V. Martinov, A. G. Plotnikov, V. M. Vitvitsky and F. I. Ataullakhanov, Deficiencies of glycolytic enzymes as a possible cause of hemolytic anemia, Biochim. Biophys. Acta, 1474 (2000), 75-87.
39. L. M. Merlo, J. W. Pepper, B. J. Reid and C. C. Maley, Cancer as an evolutionary and ecological process, Nature Rev. Cancer, 6 (2006), 924-935.
40. L. M. Merlo, N. A. Shah, X. Li, P. L. Blount, T. L. Vaughan, B. J. Reid and C. C. Maley, A comprehensive survey of clonal diversity measures in Barrett's esophagus as biomarkers of progression to esophageal adenocarcinoma, Cancer Prev. Res., 3 (2010), 1388-1397.
41. J. A. J. Metz, R. Nesbit and S. A. H. Geritz, How should we define 'fitness' for general ecological scenarios?, Trends Ecol. Evol., 7 (1992), 198-202.
42. J. D. Nagy, Competition and natural selection in a mathematical model of cancer, Bull. Math. Biol., 66 (2004), 663-687.
43. J. D. Nagy, The ecology and evolutionary biology of cancer: A review of mathematical models of necrosis and tumor cell diversity, Math. Biosci. Eng., 2 (2005), 381-418.
44. J. D. Nagy, E. M. Victor and J. H. Cropper, Why don't all whales have cancer? A novel hypothesis resolving Peto's paradox, Int. Comp. Biol., 47 (2007), 317-328.
45. N. Navin, J. Kendall, J. Troge, P. Andrews, L. Rodgers, J. McIndoo, K. Cook, A. Stapansky, D. Levy, D. Esposito, L. Muthuswamy, A. Krasnitz, W. R. McCombie, J. Hicks and M. Wiglerm, Tumour evolution inferred by single-cell sequencing, Nature, 472 (2011), 90-94.
46. G. Neufeld, T. Cohen, S. Gengrinovitch and Z. Poltorak, Vascular endothelial growth factor and its receptors, FASEB J., 13 (1999), 9-22.
47. P. C. Nowell, The clonal evolution of tumor cell populations, Science, 194 (1976), 23-28.
48. K. Parvinen, Evolutionary suicide, Acta Biotheor., 53 (2005), 241-264.
49. K. Pavlov and C. C. Maley, New models of neoplastic progression in Barrett's esophagus, Biochem. Soc. Trans., 38 (2010), 331-336.
50. C. M. Perrins, Survival of young swifts in relation to brood size, Nature, 201 (1964), 1147-1148.
51. K. H. Plate, G. Breier, H. A. Weich and W. Risau, Vascular endothelial growth factor is a potent tumour angiogenesis factor in human gliomas in vivo, Nature, 359 (1992), 845-848.
52. C. M. Robbins, W. A. Tembe, A. Baker, S. Sinari, T. Y. Moses, S. Beckstrom-Sternberg, J. Beckstrom-Sternberg, M. Barrett, J. Long, A. Chinnaiyan, J. Lowey, E. Suh, J. V. Pearson, D. W. Craig, D. B. Angus, K. J. Pienta and J. D. Carpten, Copy number and targeted mutational analysis reveals novel somatic events in metastatic prostate tumors, Genome Res., 21 (2011), 47-55.
53. Y. Rong, D. L. Durden, E. G. Van Meir and D. J. Brat, 'Pseudopalisading' necrosis in glioblastoma: A familiar morphologic feature that links vascular pathology, hypoxia and angiogenesis, J. Neuropathol. Exp. Neurol., 65 (2006), 529-539.
54. M. Tehrani, T. M. Friedman, J. J. Olson and D. J. Brat, Intravascular thrombosis in central nervous system malignancies: a potential role in astrocytoma progression to glioma, Brain Pathol., 18 (2008), 164-171.
55. P. Vajkoczy, M. Farhadi, A. Gaumann, R. Heidenreich, R. Erber, A. Wunder, J. C. Tonn, M. D. Menger and G. Breier, Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF VEGF receptor-2 and angopietin-2, J. Clin. Invest., 109 (2002), 777-785.
56. G. C. Williams, "Adaptation and Natural Selection: A Critique of Some Current Evolutionary Thought," Princeton U Press, Princeton, 1966.
57. V. C. Wynn-Edwards, Intergroup selection in the evolution of social systems, Nature, 200 (1963), 623-626.